Von in Biological Technology
Navigation Links
Von in Biological Technology
... that measures the functional activity of the von Willebrand Factor. A deficiency of von Willebrand Factor causes von Willebrand Disease -- the world's most common ...
... [6] Herberg KW, Füssgen I: Einfluss von Trospiumchlorid, Oxybutynin-HCl und ... [11] Herberg KW, Füssgen I:Einfluss von Trospiumchlorid, Oxybutynin- HCl und ... [17] Herberg KW, Füssgen I: Einfluss von Trospiumchlorid, Oxybutynin-HCl und ...
... whether therapy after childbirth for women with von Willebrand disease is needed and for ... prophylaxis treatment for postpartum women with von Willebrand disease (VWD). Investigators ... http://www.prnewswire.com/mnr/cslbehring/32474/ von Willebrand disease (VWD) is the most common ...
... Humate(R) P (Antihemophilic factor / von Willebrand Factor Complex [Human], Dried, ... the treatment of conditions such as hemophilia, von Willebrand Disease, primary immunodeficiency as ... to patients in Quebec." About Hemophilia A and von Willebrand Disease Hemophilia is a bleeding ...
... expanded opportunities for their donors and intended parents. Robin von Halle, DNA Co-Founder explains that the goal was to build a program to ... by limited resources or reproductive laws in their own country. Robin von Halle will be attending the 25th Annual Meeting of the European ...
... and blood-clotting disorders. The lab has studied the molecular basis of von Willebrand disease (VWD), the most common inherited bleeding disorder, and ... The lab has also defined mutations in ADAMTS13, an enzyme that processes von Willebrand factor, as the cause of Thrombotic Thrombocytopenia Purpura. ...
... anticancer agent in patients with advanced cancer and lymphoma", D. W. Northfelt, P. Griffin, H. Block, H. Sindermann, M. Teifel, D. von Hoff, D. Mendelson, the poster outlines Phase 1 results for this orally-active tubulin and topoisomerase II inhibitor compound, in ...
... and Alternative Reproductive Resources (ARR), both of Chicago. "DNA is needed as the fertility field grows in size and complexity," said Robin von Halle, president of ARR. "This has resulted in a proliferation of agencies that recruit egg donors, which makes weighing agency and donor choices ...
... more importantly, we hope that quarfloxin will be an effective treatment for cancer patients with limited therapeutic alternatives," added Dr. Daniel von Hoff, Cylene's Co-Founder and Vice President, Medical Affairs. "Quarfloxin has demonstrated potent in vivo efficacy against a broad range of tumors ...
... "First Phase I Trial of NKTR-102 (PEG-irinotecan) Reveals Early Evidence of Broad Anti-Tumor Activity in Three Different Schedules" -- Authors: D.D. von Hoff, G.S. Jameson, M.J. Borad, L.S. Rosen, J. Utz, M. Basche, C. Alemany, S. Dhar, L. Acosta, T. Barker, J. Walling, J.T. Hamm. About NKTR-102 ...
... the full Fiscal Year, in conjunction with the successful completion of the acquisition of ClinPhone Plc and other factors discussed herein. Josef von Rickenbach, Chairman and Chief Executive Officer of PAREXEL stated, "We are very pleased to have completed the acquisition of ClinPhone, which ...
... pioneering work in biological neural networks, aired in over a hundred publications, won him both NIH support and recognition by way of the Alexander von Humboldt Prize for Senior Distinguished American Scientists. When Pellionisz also made a bold step and published his research on the fractal ...
... June 19 /PRNewswire-FirstCall/ -- Iomai Corporation (Nasdaq: IOMI ) announced that its Chief Scientific Officer, Gregory Glenn, M.D., and Alexander von Gabain, Ph. D., the Chief Scientific Officer of Intercell AG (VSE: ICLL), will speak today at the Biotechnology Industry Organization's International ...
... [6] Herberg KW, Füssgen I: Einfluss von Trospiumchlorid, Oxybutynin-HCl und ... [11] Herberg KW, Füssgen I:Einfluss von Trospiumchlorid, Oxybutynin- HCl und ... [17] Herberg KW, Füssgen I: Einfluss von Trospiumchlorid, Oxybutynin-HCl und ...
Metabolex Announces Election of Kurt von Emster to Board of Directors
... related metabolic disorders, announced that Kurt von Emster has been elected to its Board of Directors. Mr. von Emster currently serves as a Managing Director of venBio. From November 2000 to March 2009, Mr. von Emster was Managing Director of MPM BioEquities ...San Diego universities, government and industry rally around local Clean-Tech cluster
... the City of San Diego, UC San Diego's William J. von Liebig Center for Entrepreneurism and San Diego ... technology sectors," said Rosibel Ochoa, the von Liebig Center's acting executive director. ... $50,000, plus business advisory services from the von Liebig Center's consultants. In addition, a team ...Fertility Agency Sweetens Incentives to Gestational Surrogates; Finds Interest Up
... a very special type of person," said Robin von Halle, president of ARR. "Many of our surrogates, ... health insurance to cover related costs," said von Halle. "In the current economic environment, we ... program, visit http://www.arr1.com, or contact von Halle at info@arr1.com , 773.327.7315. ...... whether therapy after childbirth for women with von Willebrand disease is needed and for ... prophylaxis treatment for postpartum women with von Willebrand disease (VWD). Investigators ... http://www.prnewswire.com/mnr/cslbehring/32474/ von Willebrand disease (VWD) is the most common ...
Tickets for Brand New Exhibition 'Body Worlds & The Mirror of Time' on Sale 18 July
... physician, scientist and anatomist Dr. Gunther von Hagens, go on sale today. (Photo: ... and well-being throughout our lives," said Dr. von Hagens Body Worlds is the only anatomical ... scientific process invented and perfected by Dr. von Hagens. James Bidwell, chief executive of Visit ...Rentschler Biotechnologie erweitert Kapazitten fr Produktion in Sugetierzellen
... GMP-Produktionslinien mit Arbeitsvolumen von 30, 250, 500 und 2.500 Litern für die Herstellung von klinischen Prüfmustern und für die ... Produktionsbedarf die Kapazitäten von Rentschler übersteigt, Zugang zu Boehringer ...... Humate(R) P (Antihemophilic factor / von Willebrand Factor Complex [Human], Dried, ... the treatment of conditions such as hemophilia, von Willebrand Disease, primary immunodeficiency as ... to patients in Quebec." About Hemophilia A and von Willebrand Disease Hemophilia is a bleeding ...
Seneca Valley High School Student Receives Science Award From MedImmune
... "Discovering New Splicing Forms in von Willebrand Factor to Understand Clotting ... of the project submitted, Li was interested in von Willebrand disease (VWD) and understanding the ... that affects the blood's ability to clot. von Willebrand factor (VWF) is a protein that helps ...CSL Behring Expands Into Middle East Market with Haemate(R) P
... High levels of Type III von Willebrand Disease, a serious, hereditary ... Haemate P is indicated for the treatment of von Willebrand Disease, a serious, hereditary, ... caused by a deficiency or abnormality of the von Willebrand factor, a protein in the blood that is ...... expanded opportunities for their donors and intended parents. Robin von Halle, DNA Co-Founder explains that the goal was to build a program to ... by limited resources or reproductive laws in their own country. Robin von Halle will be attending the 25th Annual Meeting of the European ...
Researchers solve 'bloodcurdling' mystery
... "force sensor" known as the A2 domain of the blood clotting protein von Willebrand factor (VWF). By manipulating single molecules of this A2 ... injury. It also gives insight into how bleeding disorders, such as type 2A von Willebrand disease, disrupt this regulation system, potentially leading to ...PAREXEL Reports Third Quarter Fiscal Year 2009 Financial Results
... less cancellations divided by service revenue). Mr. Josef H. von Rickenbach, PAREXEL's Chairman and Chief Executive Officer stated, "The ... new business wins in the quarter, despite some market headwinds." Mr. von Rickenbach continued, "I remain confident regarding PAREXEL's prospects ...... and blood-clotting disorders. The lab has studied the molecular basis of von Willebrand disease (VWD), the most common inherited bleeding disorder, and ... The lab has also defined mutations in ADAMTS13, an enzyme that processes von Willebrand factor, as the cause of Thrombotic Thrombocytopenia Purpura. ...
Video: Moms Raise 'Red Flag' About the Dangers of Widely Undiagnosed Bleeding Disorder
... National Campaign Highlights Signs, Symptoms, Impact on Families of von Willebrand Disease NEW YORK, Sept. 23 ... are used in the treatment of immune deficiency disorders, hemophilia, von Willebrand disease, other bleeding disorders and inherited emphysema. ...PAREXEL Reports Fourth Quarter and Fiscal Year 2008 Financial Results
... 1.56 for the quarter, and was 1.57 for Fiscal Year 2008. Mr. Josef H. von Rickenbach, PAREXEL's Chairman and Chief Executive Officer stated, "The ... to solid operating margin expansion during the Fiscal Year." Mr. von Rickenbach continued, "We have clearly benefited from the successful ...PAREXEL Promotes Dr. Mark A. Goldberg to Chief Operating Officer
... He will continue to oversee these areas of the Company and report to Josef von Rickenbach, Chairman and Chief Executive Officer of PAREXEL. "Dr. ... recent extension of our capabilities in the Asia-Pacific region," said Mr. von Rickenbach. "Dr. Goldberg has led the strong performance in Clinical ...ARR Offers Parents 'Extended Choice' in Egg Donor Selections
... "And we don't typically charge for this part of our service, either," said von Halle. "But we believe some of our clients will like this option and ... intended parents from around the world. For further information, contact von Halle at 773.327.7315, or info@arr1.com . ...JCI table of contents: April 22, 2008
... is discussed in an accompanying commentary by Tom Van Belle and Matthias von Herrath, at the La Jolla Institute for Allergy and Immunology. TITLE: ... Immunosuppression in islet transplantation AUTHOR CONTACT: Matthias von Herrath La Jolla Institute for Allergy and Immunology, La Jolla, ...Phytomedics Inc. Appoints Dr. Laurie Smaldone Alsup, MD., as President and Chief Executive Officer
... development as well as executive leadership in various roles," said Aki von Roy, chairman of Phytomedics board of directors. "Her distinguished career ... a potential blockbuster product already in late stage development," said von Roy. "We now look forward to a new era in our company's development as we ...Maryland Science Center Unveils Anatomical Exhibition, Body Worlds 2, on Saturday, February 2
... BALTIMORE, Feb. 1 /PRNewswire/ -- Gunther von Hagens' BODY WORLDS 2: The Original Exhibition of Real Human Bodies will ... with reactive resins and polymers - was invented by Dr. Gunther von Hagens, physician, anatomist and creator of the exhibitions that bear his ...PAREXEL Reports First Quarter Fiscal Year 2008 Financial Results
... 2007. The net book-to-burn ratio in the quarter was 1.31. Mr. Josef H. von Rickenbach, PAREXEL's Chairman and Chief Executive Officer stated, "During ... our global footprint in the rapidly growing Asia Pacific market." Mr. von Rickenbach continued, "We believe that the market demand for our services ...PAREXEL International Completes Acquisition of APEX International Clinical Research Co., Ltd.
... for a wide range of clinical development activities," stated Josef von Rickenbach, Chairman and Chief Executive Officer of PAREXEL International. ... providers of biopharmaceutical services in the Asia-Pacific region." Mr. von Rickenbach continued, "Our long-term alliance with APEX and subsequent ...... anticancer agent in patients with advanced cancer and lymphoma", D. W. Northfelt, P. Griffin, H. Block, H. Sindermann, M. Teifel, D. von Hoff, D. Mendelson, the poster outlines Phase 1 results for this orally-active tubulin and topoisomerase II inhibitor compound, in ...
... and Alternative Reproductive Resources (ARR), both of Chicago. "DNA is needed as the fertility field grows in size and complexity," said Robin von Halle, president of ARR. "This has resulted in a proliferation of agencies that recruit egg donors, which makes weighing agency and donor choices ...
PAREXEL Appoints Josephine Hoppe to Chief Information Officer
... as one of the world's largest users of these technologies is an important differentiator in the value we are able to deliver to clients," said Josef von Rickenbach, Chairman and Chief Executive Officer of PAREXEL International. "In this regard, we look forward to Jo's innovation and leadership in ...PAREXEL International to Present at the 27th Annual JP Morgan Healthcare Conference
... PRXL ) announced today it will be presenting at the 27th Annual JP Morgan Healthcare Conference at The Westin St. Francis in San Francisco. Josef von Rickenbach, Chairman and Chief Executive Officer will be making a formal presentation on PAREXEL at 10:00 a.m. PT on Tuesday, January 13, 2009. ...... more importantly, we hope that quarfloxin will be an effective treatment for cancer patients with limited therapeutic alternatives," added Dr. Daniel von Hoff, Cylene's Co-Founder and Vice President, Medical Affairs. "Quarfloxin has demonstrated potent in vivo efficacy against a broad range of tumors ...
PAREXEL Receives Best CRO Award from Scrip
... healthcare." "PAREXEL is honored to be chosen as the Best Contract Research Organization by the judges of the Scrip Awards," said Josef von Rickenbach, Chairman and Chief Executive Officer of PAREXEL International. "We have a deep commitment to expanding partnerships with ...Herculex Receives Regulatory Approval in Brazil
... Contacts: DuPont Brazil: Jhoryka Melo +55-11-4166-8182 Outside Brazil: Patrick Arthur 515-334-6515 Dow AgroSciences Brazil: Mario von Zuben +55-99136-384 Outside Brazil: Garry Hamlin 317-337-4799 Herculex® Insect Protection technology by Dow AgroSciences and Pioneer ...... "First Phase I Trial of NKTR-102 (PEG-irinotecan) Reveals Early Evidence of Broad Anti-Tumor Activity in Three Different Schedules" -- Authors: D.D. von Hoff, G.S. Jameson, M.J. Borad, L.S. Rosen, J. Utz, M. Basche, C. Alemany, S. Dhar, L. Acosta, T. Barker, J. Walling, J.T. Hamm. About NKTR-102 ...
Affitech Appoints Dr. Keith McCullagh as Chairman
... biotech companies will be of great value as we enter the next phase of Affitech's growth and development." Affitech also announced that Thomas von Rueden has retired as a director, having completed his term of office. Notes to Editors: About Affitech Affitech AS is a privately held human ...... the full Fiscal Year, in conjunction with the successful completion of the acquisition of ClinPhone Plc and other factors discussed herein. Josef von Rickenbach, Chairman and Chief Executive Officer of PAREXEL stated, "We are very pleased to have completed the acquisition of ClinPhone, which ...
New Recombinant XYNTHA Now Available for Patients with Hemophilia A
... A (congenital factor VIII deficiency or classic hemophilia) and for surgical prophylaxis in patients with hemophilia A. XYNTHA does not contain von Willebrand factor and, therefore, is not indicated in Von Willebrand's disease. Important Safety Information for XYNTHA -- Anaphylaxis and severe ...CSL Behring's Innovative HeliTrax(SM) System Helps Physicians Manage Hemophilia A Patients
... and recombinant products and related services. The company's therapies are used in the treatment of immune deficiency disorders, hemophilia, von Willebrand disease, other bleeding disorders and inherited emphysema. Other products are used for the prevention of hemolytic disease of the newborn, ...PAREXEL Closes the Acquisition of ClinPhone
... and service providers with the benefits of an extensive line of products and services throughout the entire clinical development lifecycle. Josef von Rickenbach, Chairman and Chief Executive Officer of PAREXEL International, said: "Biopharmaceutical companies require robust technology solutions to ...... pioneering work in biological neural networks, aired in over a hundred publications, won him both NIH support and recognition by way of the Alexander von Humboldt Prize for Senior Distinguished American Scientists. When Pellionisz also made a bold step and published his research on the fractal ...
... June 19 /PRNewswire-FirstCall/ -- Iomai Corporation (Nasdaq: IOMI ) announced that its Chief Scientific Officer, Gregory Glenn, M.D., and Alexander von Gabain, Ph. D., the Chief Scientific Officer of Intercell AG (VSE: ICLL), will speak today at the Biotechnology Industry Organization's International ...
Parexel Invites Public to Listen to Live Webcast of Its Investor Day June 25, 2008
... June 25, 2008, from 8:30 a.m. to 12:30 p.m. (EDT). All interested parties are invited to listen as Chairman and Chief Executive Officer Josef von Rickenbach, Chief Financial Officer Jim Winschel and five additional members of the executive team provide a strategic overview of the Company's ...Other ContentschickenchickenchickenchickenchickenchickenpoxchickenpoxchillchillchillchildchildchildchildchildchildchildchildchildchildbirthchildbirthchillschillschlamydiachlamydiachlamydiachlamydiaOther TagsAdmitOther Tagsnew 2new 3new 4new 5new 6new 7new 8new 9new 10tumors 2tumors 3tumors 4tumors 5tumors 6tumors 7tumors 8tumors 9tumors 10brain 2brain 3brain 4brain 5brain 6brain 7brain 8brain 9brain 10risk 2risk 3risk 4risk 5risk 6risk 7risk 8risk 9risk 10increased 2increased 3increased 4increased 5increased 6increased 7increased 8increased 9increased 10with 2with 3with 4with 5with 6with 7with 8with 9with 10
(Date:11/25/2009)... , LA JOLLA, CAWhen you eat may be just as vita...s at the Salk Institute for Biological Studies. Th...xing and waning of thousands of genes in the liver...lled by food intake and not by the body,s circadia...eding time determines the activity of a large numb...
(Date:11/24/2009)... , The Lupus Research Institute (LRI) today named...aling $3.6 million, recognize innovative work acro...lected for their creativity, novelty, and potentia...ent, treat, and cure the complex disease of system...stablished lupus researchers across the nation and...
(Date:11/24/2009)... , Scientists have crystallised a protein that ma...ract. The protein could be used by probiotic produ...real benefit to people. , "Probiotics need to int...al effect, and if they attach to surfaces in the g...h to exert their activity," says Dr Nathalie Juge ...
Breaking Biology News(10 mins):Feeding the clock 2Feeding the clock 3Lupus Research Institute announces 2009 novel research grants 2Lupus Research Institute announces 2009 novel research grants 3A sticky solution for identifying effective probiotics 2Prostate Cancer Over Diagnosed 3A Study 55767 1Prostate Cancer Over Diagnosed 3A Study 55767 2Prostate Cancer Over Diagnosed 3A Study 55767 3Mediterranean Diet May Be Best for Type 2 Diabetes 55765 1Mediterranean Diet May Be Best for Type 2 Diabetes 55765 2Mediterranean Diet May Be Best for Type 2 Diabetes 55765 3Retail Medical Clinics Offer Quality Care 3A Study 55763 1Retail Medical Clinics Offer Quality Care 3A Study 55763 2Retail Medical Clinics Offer Quality Care 3A Study 55763 3(Date:11/27/2009)...otech firm Replikins Ltd. today issued its latest ...a. It shows that the lethality of the virus has d...virus,s current outbreak in the spring of 2009 to ... 0.1). The H1N1 infectivity count, however, remain...WEB) November 27, 2009 -- Biotech firm Replikins L...
(Date:11/27/2009)...v. 27 The Gymboree Corpo...rt, CFO/COO, will present at the NASDAQ OMX 23rd I...r Hotel in London, England, on Wednesday, December...live broadcast of The Gymboree Corporation,s prese...mboree.com, click on "Our Company" at the bottom o...
(Date:11/27/2009)...INE, France, Nov. 27 Team Garmin-S... team dedicated to ethical sporting and developing...ed today that it will become Team Garmin-Transitio...ew sponsor of the team. Transitions Optical is the... offering the most advanced photochromic technolog...
(Date:11/27/2009)...naCare Holdings has announced that it has become a... of the largest nonprofit organizations dedicated ... , Delray Beach, FL (Vocu...TCBB: XCHO), a company specializing in the marketi...products, has announced today that is has become a...
(Date:11/27/2009)...cedented medical, economic burdens, study predicts... The number of people with diabetes in the United ...s, a new study predicts. , That would bring the...he disease, up from 23.7 million today. , , At t...betes will triple, the study also warns, rising fr...
Breaking Medicine News(10 mins):Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 2Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 3Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 4Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 5Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 2Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 3Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 2Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 3Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 4Health News:Diabetes Cases Expected to Double in 25 Years 2Health News:Diabetes Cases Expected to Double in 25 Years 3[0] Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased[0] The Gymboree Corporation to Present at NASDAQ OMX 23rd Investor Program[0] Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor[0] XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation [0] Diabetes Cases Expected to Double in 25 Years
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |